MedPath

to study the effect of intra peritoneal levobupivacaine on post operative pain in patients who have undergone Diagnostic laparoscopy

Not Applicable
Conditions
Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Registration Number
CTRI/2022/11/047429
Lead Sponsor
rohilkhand medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)ASA risk classification1-2.

2) All women undergoing diagnostic laparoscopic surgery.

Exclusion Criteria

1)ASA >2

2) Wt <50kg due to risk of local anesthesia toxicity

3) Contra-indication or previous adverse reaction to bupivacaine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
main aim of this randomized triple blinded study was to compare post laparoscopic pain in women treated with Levobupivacaine with those treated with 0.9 <br/ ><br>% sodium chloride <br/ ><br>Timepoint: 1 year <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To compare the efficiency of Intraperitoneal instillation of Levobupivacaine with that <br/ ><br>of Intraperitoneal instillation of 0.9% sodium chloride in terms of: <br/ ><br>â?¢ Duration of pain relieving action <br/ ><br>â?¢ Need of post-operative analgesia <br/ ><br>â?¢ Quality of post-operative careTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath